2 Jun 2025 • In adults with type 1 diabetes (T1D), metabolic dysfunction-associated steatotic liver disease (MASLD)—present in 16.8%—was strongly associated with higher rates of atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease (9.9% vs. 4.7%), peripheral artery disease (9.0% vs. 2.2%), and stroke (6.3% vs. 1.1%).

MASLD increased the odds of ASCVD over fourfold (adjusted OR = 4.26, p < 0.001), and was linked to higher 5-year (7.8% vs. 4.8%) and 10-year (15.0% vs. 9.4%) ASCVD risk.

Findings highlight MASLD as a key cardiovascular risk marker in T1D.

Source: RBMO Journal | Read Full Story